In addition to Wockhardt's development and finished dosage form capabilities, we boast a state-of-the-art cGMP compliant API manufacturing facility approved by the USFDA and UKMHRA.
Key Manufacturing Capabilities & Attributes:
Key Manufacturing Capabilities & Attributes:
- State-of-the-art facility to manufacture sterile cephalosporins API's
- Flexibility to manufacture high value - low volume products and high volume products
- Multipurpose plant which can manufacture several products at a time handling high pressure, high temperature (up to 250 degrees Celsius) and low temperature (up to -70 degrees Celsius) reactions
- Macrolide production
- DMF's filed during last three years is 30+
- API's developed in last three years is 50+
Key Research Capabilities & Attributes:
- R&D team consisting 70+ scientists of which 20+ scientists are PhD's
- API R&D team is supported by a dedicated analytical group comprising 40 scientists, of which 5 are Ph.Ds.
- 30 years of API process research experience
- Excellent History of precise and timely implementation of projects
- Development of solutions to generate robust API processes.
- Equilibrium between low cost and high value added work
- API's developed to date is 150+